These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 33149541)

  • 21. Selective pressure on SARS-CoV-2 protein coding genes and glycosylation site prediction.
    Lo Presti A; Rezza G; Stefanelli P
    Heliyon; 2020 Sep; 6(9):e05001. PubMed ID: 32984566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An entropy-based study on the mutational landscape of SARS-CoV-2 in USA: Comparing different variants and revealing co-mutational behavior of proteins.
    Santoni D
    Gene; 2024 Sep; 922():148556. PubMed ID: 38754568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV-2 Genomes From Oklahoma, United States.
    Narayanan S; Ritchey JC; Patil G; Narasaraju T; More S; Malayer J; Saliki J; Kaul A; Agarwal PK; Ramachandran A
    Front Genet; 2020; 11():612571. PubMed ID: 33613621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The First Geographic Identification by Country of Sustainable Mutations of SARS-COV2 Sequence Samples: Worldwide Natural Selection Trends.
    Mahmanzar M; Houseini ST; Rahimian K; Namini AM; Gholamzad A; Tokhanbigli S; Sisakht MM; Farhadi A; Kuehu DL; Deng Y
    bioRxiv; 2022 Jul; ():. PubMed ID: 35898341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Similarity between mutation spectra in hypermutated genomes of rubella virus and in SARS-CoV-2 genomes accumulated during the COVID-19 pandemic.
    Klimczak LJ; Randall TA; Saini N; Li JL; Gordenin DA
    bioRxiv; 2020 Aug; ():. PubMed ID: 32793907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Energetic and frustration analysis of SARS-CoV-2 nucleocapsid protein mutations.
    Haque S; Khatoon F; Ashgar SS; Faidah H; Bantun F; Jalal NA; Qashqari FSI; Kumar V
    Biotechnol Genet Eng Rev; 2023 Oct; 39(2):1234-1254. PubMed ID: 36708355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of single nucleotide polymorphisms between 2019-nCoV genomes and its impact on codon usage.
    Gupta S; Paul P; Singh R
    Gene Rep; 2021 Sep; 24():101185. PubMed ID: 33969236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimal entropic properties of SARS-CoV-2 RNA sequences.
    Formentin M; Chignola R; Favretti M
    R Soc Open Sci; 2024 Jan; 11(1):231369. PubMed ID: 38298394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Recovery from Mild Coronavirus Disease 2019.
    Lee JS; Kim SY; Kim TS; Hong KH; Ryoo NH; Lee J; Park JH; Cho SI; Kim MJ; Kim YG; Kim B; Shin HS; Oh HS; Seo MS; Gwon TR; Kim Y; Park JS; Chin BS; Park WB; Park SS; Seong MW
    Clin Infect Dis; 2021 Nov; 73(9):e3002-e3008. PubMed ID: 33219681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Large scale genomic analysis of 3067 SARS-CoV-2 genomes reveals a clonal geo-distribution and a rich genetic variations of hotspots mutations.
    Laamarti M; Alouane T; Kartti S; Chemao-Elfihri MW; Hakmi M; Essabbar A; Laamarti M; Hlali H; Bendani H; Boumajdi N; Benhrif O; Allam L; El Hafidi N; El Jaoudi R; Allali I; Marchoudi N; Fekkak J; Benrahma H; Nejjari C; Amzazi S; Belyamani L; Ibrahimi A
    PLoS One; 2020; 15(11):e0240345. PubMed ID: 33170902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Progression of SARS Coronavirus 2 (SARS-CoV2): Mutation in the Receptor Binding Domain of Spike Gene.
    Kim S; Lee JH; Lee S; Shim S; Nguyen TT; Hwang J; Kim H; Choi YO; Hong J; Bae S; Jhun H; Yum H; Lee Y; Chan ED; Yu L; Azam T; Kim YD; Yeom SC; Yoo KH; Kang LW; Shin KC; Kim S
    Immune Netw; 2020 Oct; 20(5):e41. PubMed ID: 33163249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2.
    Linsky TW; Vergara R; Codina N; Nelson JW; Walker MJ; Su W; Barnes CO; Hsiang TY; Esser-Nobis K; Yu K; Reneer ZB; Hou YJ; Priya T; Mitsumoto M; Pong A; Lau UY; Mason ML; Chen J; Chen A; Berrocal T; Peng H; Clairmont NS; Castellanos J; Lin YR; Josephson-Day A; Baric RS; Fuller DH; Walkey CD; Ross TM; Swanson R; Bjorkman PJ; Gale M; Blancas-Mejia LM; Yen HL; Silva DA
    Science; 2020 Dec; 370(6521):1208-1214. PubMed ID: 33154107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lysine 164 is critical for SARS-CoV-2 Nsp1 inhibition of host gene expression.
    Shen Z; Zhang G; Yang Y; Li M; Yang S; Peng G
    J Gen Virol; 2021 Jan; 102(1):. PubMed ID: 33151142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Global SNP analysis of 11,183 SARS-CoV-2 strains reveals high genetic diversity.
    Yuan F; Wang L; Fang Y; Wang L
    Transbound Emerg Dis; 2021 Nov; 68(6):3288-3304. PubMed ID: 33207070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Humanized COVID-19 decoy antibody effectively blocks viral entry and prevents SARS-CoV-2 infection.
    Huang KY; Lin MS; Kuo TC; Chen CL; Lin CC; Chou YC; Chao TL; Pang YH; Kao HC; Huang RS; Lin S; Chang SY; Yang PC
    EMBO Mol Med; 2021 Jan; 13(1):e12828. PubMed ID: 33159417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and characterization of novel RdRp and Nsp15 inhibitors for SARS-COV2 using computational approach.
    Barage S; Karthic A; Bavi R; Desai N; Kumar R; Kumar V; Lee KW
    J Biomol Struct Dyn; 2022 Apr; 40(6):2557-2574. PubMed ID: 33155531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Saporin, a Polynucleotide-Adenosine Nucleosidase, May Be an Efficacious Therapeutic Agent for SARS-CoV-2 Infection.
    Arslan I; Akgul H; Kara M
    SLAS Discov; 2021 Mar; 26(3):330-335. PubMed ID: 33155515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sitagliptin: a potential drug for the treatment of COVID-19?
    Bardaweel SK; Hajjo R; Sabbah DA
    Acta Pharm; 2021 Jun; 71(2):175-184. PubMed ID: 33151168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of potential COVID-19 main protease inhibitors using structure-based pharmacophore approach, molecular docking and repurposing studies.
    Daoud S; Alabed SJ; Dahabiyeh LA
    Acta Pharm; 2021 Jun; 71(2):163-174. PubMed ID: 33151166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cordycepin: a bioactive metabolite of C
    Verma AK
    J Biomol Struct Dyn; 2022 May; 40(8):3745-3752. PubMed ID: 33225826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.